Analysis of the Correlation between Expressions of HSP90α, HSP90β, and GRP94, and the Clinicopathologic Characteristics in Tissues of Non-Small Cell Lung Cancer Patients
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Heat shock proteins (HSPs) are induced as a self-defense mechanism of cells when exposed to various external stresses, such as high fever, infection, free radicals, and heavy metals. They affect the prognosis in the process of tumor formation. HSP is classified into four families: HSP27, HSP60, HSP90, and HSP100, depending on molecular weight. Heat shock protein 90 (HSP90), a molecular chaperone, plays an important role in the cellular protection against various stressful stimuli and in the regulation of cell cycle progression and apoptosis. In the present study, we assessed the differential expression of HSP90 family proteins in non-small cell lung cancer (NSCLC), and the correlation of their expression levels with clinicopathologic factors and patient survival rates. The result of this study can be summarized as follows; HSP90α showed higher expression in patients with no lymphovascular invasion (p=0.014). HSP90β showed a higher expression of squamous cell carcinoma (p=0.003), and an over expression of glucose-related protein (GRP94) was significantly associated with poor differentiation (p=0.048). However, none of the HSP90 proteins showed a significant association with the survival status in patients with NSCLC. This study also indicates that HSP90α might contribute more to the carcinogenesis of NSCLC than HSP90β, and GRP94 and isoform selectivity should be considered when HSP90 inhibitors are studied or utilized in the treatment of NSCLC.
Abstract
Heat shock proteins (HSPs) are induced as a self-defense mechanism of cells when exposed to various external stresses, such as high fever, infection, free radicals, and heavy metals. They affect the prognosis in the process of tumor formation. HSP is classified into four families: HSP27, HSP60, HSP90, and HSP100, depending on molecular weight. Heat shock protein 90 (HSP90), a molecular chaperone, plays an important role in the cellular protection against various stressful stimuli and in the regulation of cell cycle progression and apoptosis. In the present study, we assessed the differential expression of HSP90 family proteins in non-small cell lung cancer (NSCLC), and the correlation of their expression levels with clinicopathologic factors and patient survival rates. The result of this study can be summarized as follows; HSP90α showed higher expression in patients with no lymphovascular invasion (p=0.014). HSP90β showed a higher expression of squamous cell carcinoma (p=0.003), and an over expression of glucose-related protein (GRP94) was significantly associated with poor differentiation (p=0.048). However, none of the HSP90 proteins showed a significant association with the survival status in patients with NSCLC. This study also indicates that HSP90α might contribute more to the carcinogenesis of NSCLC than HSP90β, and GRP94 and isoform selectivity should be considered when HSP90 inhibitors are studied or utilized in the treatment of NSCLC.
참고문헌 (30)
- "GLOBOCAN 2012: Estimated cancer incidence, mortality and prevalence worldwide in 2012" (2012)[URL]
- "Cancer Statistics in Korea. 2014" (2014)[URL]
- Brandao GD, "The role of molecular pathology in non-small-cell lung carcinoma-now and in the future", Curr Oncol, 19(1), pp.24~32 (2012)
- Kingstone RE, "Regulation of heat shock protein 70 gene expression by c-myc", Nature, 312(5991), pp.280~282 (1984)
- Konno A, "Heat or stress inducible transformation associated cell surface antigen on the H-ras oncogene transfected rat fibroblasts", Cancer Res, 49(23), pp.6578~6582 (1989)
- Shrivastava PK, "Stress induced proteins in immune response to cancer", Curr Top Microbiol Immunol, 167, pp.109~123 (1991)
- Bukau B, "The Hsp70 and Hsp60 chaperone machines", Cell, 92(3), pp.351~366 (1998)
- Garcia-Carbonero R, "Inhibition of HSP90 molecular chaperones: moving into the clinic", Lancet Oncol, 14(9), pp.358~369 (2013)
- McClellan AJ, "Diverse cellular functions of the Hsp90 molecular chaperone uncovered using systems approaches", Cell, 131(1), pp.121~135 (2007)
- Dobo C, "HSP27 is Commonly Expressed in Cervical Intraepithelial Lesions of Brazilian Women", Asian Pac J Cancer Prev, 14(9), pp.5007~5010 (2013)
- Wu GQ, "Multiplex Real-time PCR for RRM1, XRCC1, TUBB3 and TS mRNA for prediction of response of non-small cell lung cancer to chemoradiotherapy", Asian Pac J Cancer Prev, 15(10), pp.4153~4158 (2014)
- Hanahan D, "The hallmarks of cancer", Cell, 100(1), pp.57~70 (2000)
- Mahalingam D, "Targeting HSP90 for cancer therapy", Br J Cancer, 100(10), pp.1523~1529 (2009)
- Sharp S, "Inhibitors of the HSP90 molecular chaperone:current status", Adv Cancer Res, 95, pp.323~348 (2006)
- Hanahan D, "Hallmarks of cancer: the next generation", Cell, 144(5), pp.646~674 (2011)
- Beck R, "Molecular chaperone Hsp90 as a target for oxidant-based anticancer therapies", Curr Med Chem, 18(18), pp.2816~2825 (2011)
- Moser C, "Heat-shock protein 90(Hsp90)as a molecular target for therapy of gastrointestinal cancer", Anticancer Res, 29(6), pp.2031~2042 (2009)
- Whitesell L, "Hsp90 and chaperoning of cancer", Nat Rev Cancer, 5(10), pp.761~772 (2005)
- Jia JM, "Synthesis and evaluation of a novel class Hsp90 inhibitors containing 1-phenylpiperazine scaffold", Bioorg Med Chem Lett, 24(6), pp.1557~1561 (2014)
- Jiang H, "Cytoplasmic HSP90α expression is associated with perineural invasion in pancreatic cancer", Int J Clin Exp Pathol, 7(6), pp.3305~3311 (2014)
- Tian WL, "High expression of heat shock protein 90 alpha and its significance in human acute leukemia cells", Gene, 542(2), pp.122~128 (2014)
- Romaniuk A, "Immune microenvironment as a factor of breast cancer progression", Diagnostic Pathology, 10, pp.79~ (2015)
- Zuo DS, "Significance of expression of heat shock protein90α in human gastric cancer", World J Gastroenterol, 9(11), pp.2616~2618 (2003)
- Jahns F, "Impact of butyrate on PKM2 and HSP90β expression in human colon tissues of different transformation stages: a comparison of gene and protein data", Genes Nutr, 7(2), pp.235~246 (2012)
- Mayer P, "Expression and therapeutic relevance of heat-shock protein 90 in pancreatic endocrine tumors", Endocr Relat Cancer, 19(3), pp.217~232 (2012)
- Lee JH, "Differential expression of heat shock protein 90 isoforms in small cell lung cancer", Int J Clin Exp Pathol, 8(8), pp.9487~9493 (2015)
- Biaoxue R, "Upregulation of Hsp90-beta and annexin A1 correlates with poor survival and lymphatic metastasis in lung cancer patients", J Exp Clin Cancer Res, 31(1), pp.70~ (2012)
- Chhabra S, "High expression of endoplasmic reticulum chaperone grp94 is a novel molecular hallmark of malignant plasma cells in multiple myeloma", J Hematol Oncol, 8, pp.77~ (2015)
- Shen J, "Glucose-regulated protein 94 deficiency induces squamous cell metaplasia and suppresses PTEN-null driven endometrial epithelial tumor development", Oncotarget, 7(12), pp.14885~14897 (2016)
- Wang Q, "Overexpression of endoplasmic reticulum molecular chaperone GRP94 and GRP78 in human lung cancer tissues and its significance", Cancer Detect Prev, 29(6), pp.544~551 (2005)